Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES

ACCRUED EXPENSES

9 Months Ended

Sep. 30, 2024

ACCRUED EXPENSES

ACCRUED EXPENSES

NOTE 9. ACCRUED EXPENSES

Accrued expenses consisted of the following:


		September 30,			December 31,
($’s in thousands)		2024			2023
Accrued expenses:
Accrued coupons and rebates		$	6,321		$	9,987
Return reserve			3,430			4,077
Accrued compensation			2,588			3,374
Accrued royalties payable			1,601			2,015
Accrued legal, accounting and tax			567			185
Accrued marketing and market access			673			—
Accrued research and development			248			20
Accrued inventory			355			352
Accrued iPledge program			90			174
Other			135			166
Total accrued expenses		$	16,008		$	20,350